AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026. Management will participate in a fireside chat at 9:40 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn, Facebook, Instagram, X and YouTube.

Media:

Marianne Ostrogorski
(224) 240-6336

marianne.ostrogorski@abbvie.com

Investors:

Liz Shea
(847) 935-2211

liz.shea@abbvie.com

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302787501.html

SOURCE AbbVie

News Provided by PR Newswire via QuoteMedia

AbbVie ABBV nyse:abbv pharmaceutical investing

ABBV

Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

- Approval is based on results from the Phase 3 SELECT-AXIS 2 pivotal clinical trial in which RINVOQ delivered rapid and meaningful disease control, meeting the primary endpoint of ASAS40 response at week 14 versus placebo 1 - RINVOQ is the first and only Janus Kinase (JAK) inhibitor approved to... Keep Reading...

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

- Oral presentations highlight efficacy and safety outcomes from the upadacitinib (RINVOQ ® ) clinical trial program in adults with moderately to severely active Crohn's disease, and investigational use of linaclotide (LINZESS ® ) in treating functional constipation in pediatric patients aged 6... Keep Reading...

Interactive Chart

Latest Press Releases

Related News

copper investing

AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics

Eli Lilly to Buy Psychedelics Firm AtaiBeckley for US$2.8 Billion

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT

Zymeworks Expands into Respiratory Market with Theravance Buyout

Merck KGaA to Acquire Bio-Techne in US$11.3 Billion Deal

Latest News

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT

Interactive Chart

Latest Press Releases

Goldgroup Mining and Gold Resource Corporation Announce Closing of Business Combination and Goldgroup's Anticipated Listing on the NYSE American

Canadian Investment Regulatory Organization Trade Resumption - GGA

Generation Uranium Announces CSE Listing and Voluntary TSXV Delisting

After Expected Business Combination of Gold Resource and Goldgroup Mining, Combined Company Will Be Ineligible for Russell 2000 Comprehensive Factor Index Due to National Eligibility Requirements

Related News

Top 5 Canadian Mining Stocks This Week: Sandfire Resources America Spikes 72 Percent

Dana Samuelson: Gold, Silver Bottom? Watch These Key Price Levels

Andy Schectman: Gold Price is Misdirection — What to Watch Instead

Goldgroup Mining and Gold Resource Corporation Announce Closing of Business Combination and Goldgroup's Anticipated Listing on the NYSE American

Craig Parry: The World Needs More Copper, but New Mines Aren't Coming Fast Enough

Canadian Investment Regulatory Organization Trade Resumption - GGA

Generation Uranium Announces CSE Listing and Voluntary TSXV Delisting

TOP STOCKS